Britain’s vaccines regulator advised on Friday that all adults under 40 in the country should be offered alternatives to AstraZeneca’s Covid-19 vaccine. It factored in concerns over very rare blood clots, the dwindling risk of severe coronavirus infection in younger adults and the availability of alternatives. The guidance extends earlier advice that people under 30 would be offered alternative doses. It said that this new reality paired with the availability of alternative vaccines had factored into the decision. The cases identified in the country more than doubled from 202 to 520 in the week, but still account for just a fraction of the cases there.

Source: New York Times May 07, 2021 12:35 UTC